Capsaicin inhibits Porphyromonas gingivalis growth, biofilm formation, gingivomucosal inflammatory cytokine secretion, and in vitro osteoclastogenesis

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 33, Issue 2, 2014, Pages 211-219

  Zhou, Y ^a,b   Guan, X ^a   Zhu, W ^a   Liu, Z ^c   Wang, X ^a   Yu, H ^b   Wang, H ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

^c Taizhou Municipal Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CAMPHOR; CAPSAICIN; CHLORHEXIDINE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BIOFILM; CELL PROLIFERATION; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; MALE; MINIMUM BACTERICIDAL CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OSTEOCLAST; OSTEOCLAST ACTIVITY; OSTEOCLASTOGENESIS; OSTEOLYSIS; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL; RAT; WESTERN BLOTTING;

ANIMALS; ANTI-BACTERIAL AGENTS; BIOFILMS; BONE RESORPTION; CAPSAICIN; CYTOKINES; DISEASE MODELS, ANIMAL; GINGIVA; IMMUNITY, MUCOSAL; IMMUNOLOGIC FACTORS; MALE; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; RATS, SPRAGUE-DAWLEY;

EID: 84893975008     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-013-1947-0     Document Type: Article

References (46)

1. Van Dyke TE, Serhan CN (2003) Resolution of inflammation: a new paradigm for the pathogenesis of periodontal diseases. J Dent Res 82(2):82-90
2. Nakayama K (2003) Molecular genetics of Porphyromonas gingivalis: gingipains and other virulence factors. Curr Protein Pept Sci 4:389-395
3. Orozco A, Gemmell E, Bickel M, Seymour GJ (2007) Interleukin 18 and periodontal disease. J Dent Res 86(7):586-593
4. Boch JA, Wara-aswapati N, Auron PE (2001) Interleukin 1 signal transduction - current concepts and relevance to periodontitis. J Dent Res 80(2):400-407
5. Graves DT, Cochran D (2003) The contribution of interleukin-1 and tumor necrosis factor to periodontal tissue destruction. J Periodontal 74:391-401
6. Mogi M, Otogoto J, Ota N, Inagaki H, Minami M, Kojima K (1999) Interleukin 1 beta, interleukin 6, beta 2-microglobulin, and transforming growth factor-alpha in gingival crevicular fluid from human periodontal disease. Arch Oral Biol 44:535-539
7. Silva TA, Garlet GP, Fukada SY, Silva JS, Cunha FQ (2007) Chemokines in oral inflammatory diseases: apical periodontitis and periodontal disease. J Dent Res 86(4):306-319
8. Boyle WJ, Simonet WS, Lacey DL (2003) Osteoclast differentiation and activation. Nature 423:337-342
9. Loesche WJ, Grossman NS (2001) Periodontal disease as a specific, albeit chronic, infection: diagnosis and treatment. Clin Microbiol Rev 14(4):727-752
10. Pischon N, Heng N, Bernimoulin JP, Kleber BM, Willich SN, Pischon T (2007) Obesity, inflammation, and periodontal disease. J Dent Res 86(5):400-409
11. Bullon P, Morillo JM, Ramirez-Tortosa MC, Quiles JL, Newman HN, Battino M (2009) Metabolic syndrome and periodontitis: is oxidative stress a common link? J Dent Res 88(6):503-518
12. Fernandes JK, Wiegand RE, Salinas CF, Grossi SG, Sanders JJ, Lopes-Virella MF, Slate EH (2009) Periodontal disease status in Gullah African Americans with type 2 diabetes living in South Carolina. J Periodontol 80(7):1062-1068
13. Xu Q, Barrios CA, Cutright T, Zhang Newby BM (2005) Evaluation of toxicity of capsaicin and zosteric acid and their potential application as antifoulants. Environ Toxicol 20(5):467-474
14. Demirbilek S, Ersoy MO, Demirbilek S, Karaman A, Gürbüz N, Bayraktar N, Bayraktar M (2004) Small-dose capsaicin reduces systemic inflammatory responses in septic rats. Anesth Analg 99:1501-1507
15. Nagahama M, Kihara A, Kintoh H, Oda M, Sakurai J (2008) Involvement of tumour necrosis factor-α in Clostridium perfringens β-toxin-induced plasma extravasation in mice. Br J Pharmacol 153(6):1296-1302
16. Miyamoto R, Tokuda M, Sakuta T, Nagaoka S, Torii M (2005) Expression and characterization of vanilloid receptor subtype 1 in human dental pulp cell cultures. J Endod 31(9):652-658
17. CRAC . J Pharmacol Exp Ther 299:238-246
18. Wang Y, Kaminski NE, Wang DH (2005) VR1-mediated depressor effects during high-salt intake: role of anandamide. Hypertension 46:986-991
19. Gram DX, Hansen AJ, Deacon CF, Brand CL, Ribel U, Wilken M, Carr RD, Svendsen O, Ahrén B (2005) Sensory nerve desensitization by resiniferatoxin improves glucose tolerance and increases insulin secretion in Zucker Diabetic Fatty rats and is associated with reduced plasma activity of dipeptidyl peptidase IV. Eur J Pharmacol 509:211-217
20. Snitker S, Fujishima Y, Shen H, Ott S, Pi-Sunyer X, Furuhata Y, Sato H, Takahashi M (2009) Effects of novel capsinoid treatment on fatness and energy metabolism in humans: possible pharmacogenetic implications. Am J Clin Nutr 89(1):45-50
21. Wei GX, Campagna AN, Bobek LA (2006) Effect of MUC7 peptides on the growth of bacteria and on Streptococcus mutans biofilm. J Antimicrob Chemother 57:1100-1109
22. Sandoe JA, Wysome J, West AP, Heritage J, Wilcox MH (2006) Measurement of ampicillin, vancomycin, linezolid and gentamicin activity against enterococcal biofilms. J Antimicrob Chemother 57:767-770
23. Sharma S, Khan IA, Ali I, Ali F, Kumar M, Kumar A, Johri RK, Abdullah ST, Bani S, Pandey A, Suri KA, Gupta BD, Satti NK, Dutt P, Qazi GN (2009) Evaluation of the antimicrobial, antioxidant, and anti-inflammatory activities of hydroxychavicol for its potential use as an oral care agent. Antimicrob Agents Chemother 53:216-222
24. Aghaloo TL, Kang B, Sung EC, Shoff M, Ronconi M, Gotcher JE, Bezouglaia O, Dry SM, Tetradis S (2011) Periodontal disease and bisphosphonates induce osteonecrosis of the jaws in the rat. J Bone Miner Res 26:1871-1882
25. Kador PF, O'Meara JD, Blessing K, Marx DB, Reinhardt RA (2011) Efficacy of structurally diverse aldose reductase inhibitors on experimental periodontitis in rats. J Periodontol 82:926-933
26. Niederman R, Westernoff T, Lee C, Mark LL, Kawashima N, Ullman-Culler M, Dewhirst FE, Paster BJ, Wagner DD, Mayadas T, Hynes RO, Stashenko P (2001) Infection-mediated early-onset periodontal disease in P/E-selectin-deficient mice. J Clin Periodontal 28:569-575
27. Di Paola R, Briguglio F, Paterniti I, Mazzon E, Oteri G, Militi D, Cordasco G, Cuzzocrea S (2011) Emerging role of PPAR-β/δ in inflammatory process associated to experimental periodontitis. Mediat Inflamm 2011:787159
28. Takeshita S, Kaji K, Kudo A (2000) Identification and characterization of the new osteoclast progenitor with macrophage phenotypes being able to differentiate into mature osteoclasts. J Bone Miner Res 15:1477-1488
29. Cicek M, Iwaniec UT, Goblirsch MJ, Vrabel A, Ruan M, Clohisy DR, Turner RR, Oursler MJ (2007) 2-Methoxyestradiol suppresses osteolytic breast cancer tumor progression in vivo. Cancer Res 67:10106-10111
30. Heaton B, Dietrich T (2012) Causal theory and the etiology of periodontal diseases. Periodontol 2000 58:26-36
31. Wilson M (1996) Susceptibility of oral bacterial biofilms to antimicrobial agents. J Med Microbiol 44:79-87
32. Graves DT, Fine D, Teng YT, Van Dyke TE, Hajishengallis G (2008) The use of rodent models to investigate host-bacteria interactions related to periodontal diseases. J Clin Periodontol 35:89-105
33. Preshaw PM (2008) Host response modulation in periodontics. Periodontol 2000(48):92-110
34. Garlet GP, Martins W Jr, Fonseca BA, Ferreira BR, Silva JS (2004) Matrix metalloproteinases, their physiological inhibitors and osteoclast factors are differentially regulated by the cytokine profile in human periodontal disease. J Clin Periodontol 31:671-679
35. Musacchio E, Valvason C, Botsios C, Ostuni F, Furlan A, Ramonda R, Modesti V, Sartori L, Punzi L (2009) The tumor necrosis factor-alpha-blocking agent infliximab inhibits interleukin 1beta (IL-1beta) and IL-6 gene expression in human osteoblastic cells. J Rheumatol 36:1575-1579
36. Fonseca JE, Santos MJ, Canhão H, Choy E (2009) Interleukin-6 as a key player in systemic inflammation and joint destruction. Autoimmun Rev 8:538-542
37. Cronstein BN (2007) Interleukin-6 - a key mediator of systemic and local symptoms in rheumatoid arthritis. Bull NYU Hosp Jt Dis 65(Suppl 1):S11-S15
38. Han X, Lin X, Seliger AR, Eastcott J, Kawai T, Taubman MA (2009) Expression of receptor activator of nuclear factor-kappaB ligand by B cells in response to oral bacteria. Oral Microbiol Immunol 24:190-196
39. Koutouzis T, Haber D, Shaddox L, Aukhil I, Wallet SM (2009) Autoreactivity of serum immunoglobulin to periodontal tissue components: a pilot study. J Periodontol 80:625-633
40. Donati M, Liljenberg B, Zitzmann NU, Berglundh T (2009) B-1a cells and plasma cells in periodontitis lesions. J Periodontal Res 44:683-688
41. Repeke CE, Ferreira SB Jr, Claudino M, Silveira EM, de Assis GF, Avila-Campos MJ, Silva JS, Garlet GP (2010) Evidences of the cooperative role of the chemokines CCL3, CCL4 and CCL5 and its receptors CCR1+ and CCR5+ in RANKL+ cell migration throughout experimental periodontitis in mice. Bone 46:1122-1130
42. Sasaki H, Okamatsu Y, Kawai T, Kent R, Taubman M, Stashenko P (2004) The interleukin-10 knockout mouse is highly susceptible to Porphyromonas gingivalis-induced alveolar bone loss. J Periodontal Res 39:432-441
43. Lappin DF, MacLeod CP, Kerr A, Mitchell T, Kinane DF (2001) Anti-inflammatory cytokine IL-10 and T cell cytokine profile in periodontitis granulation tissue. Clin Exp Immunol 123:294-300
44. Garlet GP, Cardoso CR, Campanelli AP, Martins W Jr, Silva JS (2006) Expression of suppressors of cytokine signaling in diseased periodontal tissues: a stop signal for disease progression? J Periodontal Res 41:580-584
45. Zhang X, Teng YT (2006) Interleukin-10 inhibits Gram-negative-microbe- specific human receptor activator of NF-kappaB ligand-positive CD4+-Th1-cell-associated alveolar bone loss in vivo. Infect Immun 74:4927-4931
46. Krauss JL, Potempa J, Lambris JD, Hajishengallis G (2010) Complementary Tolls in the periodontium: how periodontal bacteria modify complement and Toll-like receptor responses to prevail in the host. Periodontol 2000 52:141-162